Revolutionizing Antiviral Therapeutics: Unveiling Innovative Approaches for Enhanced Drug Efficacy
Sandra Megantara,Agus Rusdin,Arif Budiman,Shaharum Shamsuddin,Noratiqah Mohtar,Muchtaridi Muchtaridi
DOI: https://doi.org/10.2147/ijn.s447721
IF: 7.033
2024-03-20
International Journal of Nanomedicine
Abstract:Sandra Megantara, 1, 2 Agus Rusdin, 3 Arif Budiman, 3 Shaharum Shamsuddin, 4 Noratiqah Mohtar, 5 Muchtaridi Muchtaridi 1, 2, 6 1 Department of Pharmaceutical Analysis and Medicinal Chemistry, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, 45363, Indonesia; 2 Research Collaboration Centre for Theranostic Radio Pharmaceuticals, National Research and Innovation Agency (BRIN), Sumedang, 45363, Indonesia; 3 Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, 45363, Indonesia; 4 School of Health, Universiti Sains Malaysia, Penang, 11800, Malaysia; 5 School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, 11800, Malaysia; 6 Functional Nano Powder University Center of Excellence (FiNder U CoE), Universitas Padjadjaran, Sumedang, 45363, Indonesia Correspondence: Sandra Megantara, Tel +62-813-2066-3583, Email Since the beginning of the coronavirus pandemic in late 2019, viral infections have become one of the top three causes of mortality worldwide. Immunization and the use of immunomodulatory drugs are effective ways to prevent and treat viral infections. However, the primary therapy for managing viral infections remains antiviral and antiretroviral medication. Unfortunately, these drugs are often limited by physicochemical constraints such as low target selectivity and poor aqueous solubility. Although several modifications have been made to enhance the physicochemical characteristics and efficacy of these drugs, there are few published studies that summarize and compare these modifications. Our review systematically synthesized and discussed antiviral drug modification reports from publications indexed in Scopus, PubMed, and Google Scholar databases. We examined various approaches that were investigated to address physicochemical issues and increase activity, including liposomes, cocrystals, solid dispersions, salt modifications, and nanoparticle drug delivery systems. We were impressed by how well each strategy addressed physicochemical issues and improved antiviral activity. In conclusion, these modifications represent a promising way to improve the physicochemical characteristics, functionality, and effectiveness of antivirals in clinical therapy. Keywords: antiviral drugs, current modifications, drug delivery system, physicochemical properties Virus infection is one of the diseases that causes most death in the last decade, after cardiovascular and cancer diseases. In 2020, virus infection had become the first cause of death when the coronavirus pandemic started to attack the world at the end of the year 2019. There were about 150 million cases of prevalence with the fatality rate of 7.5% caused by this coronavirus disease. In addition, the Human Immunodeficiency Virus (HIV), Hepatitis A Virus (HAV), Hepatitis B Virus (HBV), Herpes Simplex Virus (HSV), and Influenza Virus (IV) are still having a high prevalence of cases. 1 Vaccination and the use of immunomodulatory agents are valuable options for preventing and managing coronavirus infections. However, they do not guarantee immunity against the virus. Antiviral and antiretroviral drugs are currently the main therapies used for the treatment of many viral diseases, and in some cases, adjuvant therapy is also added to enhance their effectiveness. 2 There are several factors that can render drug therapy ineffective, including Multiple Drug Resistant (MDR) strains, virus mutations, and the physicochemical characteristics of drugs, such as poor water solubility and non-selective virus targeting. Furthermore, synthetic drugs can have many side effects, which can reduce the patient's quality of life. Considering the limitations, scientists have been trying several approaches to improve the physicochemical characteristics of the drugs, including structure modification and utilization of drug delivery systems. 3 In order to address the physicochemical aspects of drug therapy, including solubility, selectivity, and activity, scientists have successfully employed physical and chemical modification strategies. 4 Among the most explored methodologies are nanoparticle drug delivery systems including nanostructured lipid carriers, solid lipid nanoparticle, solid lipid nanoparticle, and hybrid nanoparticle. 5–9 Also, others type of modification like liposomes, cocrystals, solid dispersions, salt formation, and structural modification. Numerous studies pertaining to the development of antiviral drugs have been published. However, existing discussions are limited to specific modifications, such as nanoparticle and metal-based modifications. 10–12 Currently, there is an absence -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology